Literature DB >> 6130326

Lithium absorption: implications for sustained-release lithium preparations.

B E Ehrlich, J M Diamond.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6130326     DOI： 10.1016/s0140-6736(83)91726-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Fraction of theophylline in sustained-release formulation which is absorbed from the large bowel.

Authors:  D K Sommers; E C Meyer; M van Wyk; J Moncrieff
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 2.  Acute overdose with sustained release drug formulations. Perspectives in treatment.

Authors:  A Minocha; D A Spyker
Journal:  Med Toxicol       Date:  1986 Jul-Aug

3.  Proceedings of the British Pharmacological Society. London, 17th-19th December, 1984. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

Review 4.  Novel oral drug formulations. Their potential in modulating adverse effects.

Authors:  A T Florence; P U Jani
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.